A detailed history of Neuberger Berman Group LLC transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Neuberger Berman Group LLC holds 1,855 shares of MEDP stock, worth $763,981. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,855
Holding current value
$763,981
% of portfolio
0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$284.87 - $413.31 $528,433 - $766,690
1,855 New
1,855 $749,000
Q4 2023

Feb 09, 2024

BUY
$227.52 - $312.68 $461,865 - $634,740
2,030 New
2,030 $622,000
Q1 2023

May 12, 2023

BUY
$174.31 - $239.52 $40,962 - $56,287
235 Added 2.68%
8,995 $1.69 Million
Q4 2022

Feb 13, 2023

SELL
$153.06 - $226.57 $1.64 Million - $2.43 Million
-10,710 Reduced 55.01%
8,760 $1.86 Million
Q3 2022

Nov 15, 2022

SELL
$145.13 - $182.49 $1.27 Million - $1.59 Million
-8,717 Reduced 30.93%
19,470 $3.06 Million
Q2 2022

Aug 15, 2022

SELL
$130.2 - $168.03 $43,877 - $56,626
-337 Reduced 1.18%
28,187 $4.22 Million
Q1 2022

May 13, 2022

BUY
$138.87 - $214.31 $180,114 - $277,960
1,297 Added 4.76%
28,524 $4.58 Million
Q4 2021

Feb 11, 2022

BUY
$182.74 - $227.9 $50,618 - $63,128
277 Added 1.03%
27,227 $5.78 Million
Q3 2021

Nov 12, 2021

BUY
$170.18 - $198.21 $402,986 - $469,361
2,368 Added 9.63%
26,950 $5.03 Million
Q2 2021

Aug 13, 2021

BUY
$158.62 - $194.3 $3.9 Million - $4.78 Million
24,582 New
24,582 $4.34 Million
Q1 2019

May 13, 2019

SELL
$49.38 - $70.58 $199,445 - $285,072
-4,039 Closed
0 $0
Q3 2018

Nov 13, 2018

BUY
$43.25 - $63.74 $174,686 - $257,445
4,039 New
4,039 $242,000
Q1 2018

May 08, 2018

SELL
$32.03 - $39.05 $548,769 - $669,043
-17,133 Closed
0 $0
Q4 2017

Feb 14, 2018

BUY
$32.46 - $38.31 $556,137 - $656,365
17,133
17,133 $684,000

Others Institutions Holding MEDP

About Medpace Holdings, Inc.


  • Ticker MEDP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 31,099,900
  • Market Cap $12.8B
  • Description
  • Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...
More about MEDP
Track This Portfolio

Track Neuberger Berman Group LLC Portfolio

Follow Neuberger Berman Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Neuberger Berman Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Neuberger Berman Group LLC with notifications on news.